Cargando…
The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota
BACKGROUND: Chronic obstructive pulmonary disease (COPD), a prevalent, progressive respiratory disease, has become the third leading cause of death globally. Increasing evidence suggests that intestinal and pulmonary microbiota dysbiosis is associated with COPD. Researchers have shown that T helper...
Autores principales: | Jia, Yu, He, Tiantian, Wu, Di, Tong, Jiabing, Zhu, Jie, Li, Zegeng, Dong, Jingcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210581/ https://www.ncbi.nlm.nih.gov/pubmed/35729584 http://dx.doi.org/10.1186/s12967-022-03481-w |
Ejemplares similares
-
Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease
por: Xie, Jinghui, et al.
Publicado: (2023) -
The Link between Circadian Clock Genes and Autophagy in Chronic Obstructive Pulmonary Disease
por: Hu, Yuedi, et al.
Publicado: (2021) -
The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome
por: Omenetti, Sara, et al.
Publicado: (2015) -
The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story
por: Cheng, Hongyu, et al.
Publicado: (2019) -
Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis
por: Chen, Pan, et al.
Publicado: (2021)